LymphedemaV1, PascalFrancis, Corpus, bibRecord, 000340

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women

Identifieur interne : 000340 ( PascalFrancis/Corpus ); précédent : 000339; suivant : 000341

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women

Auteurs : Kathleen A. Meeske ; Jane Sullivan-Halley ; Ashley W. Smith ; Anne Mctiernan ; Kathy B. Baumgartner ; Linda C. Harlan ; Leslie Bernstein

Source :

Breast cancer research and treatment [ 0167-6806 ] ; 2009.

RBID : Pascal:09-0141950

Descripteurs français

Pascal (Inist)
- Facteur risque, Epidémiologie, Bras, Lymphoedème, Cancer du sein, Diagnostic, Négroïde, Race, Homme, Femelle, Adulte, Femme, Caucasoïde, Survivant, Hypertension artérielle, Indice masse corporelle.

English descriptors

KwdEn :
- Adult, Arm, Body mass index, Breast cancer, Caucasoid, Diagnosis, Epidemiology, Female, Human, Hypertension, Lymphedema, Negroid, Race, Risk factor, Survivor, Woman.

Abstract

Purpose Lymphedema of the arm is a potential complication of breast cancer therapy. This study examines pre-disposing factors that may operate in conjunction with treatment-related factors in the development of arm lymphedema in a large cohort of White and Black breast cancer survivors. Methods 494 women (271 White and 223 Black) with in situ to Stage III-A primary breast cancer completed a baseline interview within 18 months of diagnosis. Information on lymphedema was collected during a follow-up interview, conducted on average 50 months after diagnosis. Self-reported data were used to classify women with or without lymphedema. Multivariable logistic regression models were developed to identify risk factors for arm lymphedema. Results Arm lymphedema was associated with younger age at diagnosis (odds ratio, OR per year of age = 0.96; 95% confidence interval, CI = 0.93-0.99), positive history of hypertension (OR = 2.31; 95% CI = 1.38-3.88), obesity (OR for body mass index, BMI>30 = 2.48; 95% CI = 1.05-5.84) and having had surgery where 10 or more lymph nodes were excised (OR = 2.16; 95% CI = 1.12-4.17). While Black women had higher prevalence of arm lymphedema than White women (28% vs. 21%), race was not associated with lymphedema risk in models adjusted for multiple factors (adjusted OR = 1.01; 95% CI = 0.63-1.63). Conclusion Risk of arm lymphedema did not differ significantly for Black and White women. Risk factors identified in this study offer opportunities for interventions (weight loss, control of blood pressure, use of sentinel node biopsy where possible) for reducing incidence of lymphedema or controlling the symptoms associated with this condition.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0167-6806`
A02	`01`			`@0 BCTRD6`
A03		`1`		`@0 Breast cancer res. treat.`
A05				`@2 113`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women`
A11	`01`	`1`		`@1 MEESKE (Kathleen A.)`
A11	`02`	`1`		`@1 SULLIVAN-HALLEY (Jane)`
A11	`03`	`1`		`@1 SMITH (Ashley W.)`
A11	`04`	`1`		`@1 MCTIERNAN (Anne)`
A11	`05`	`1`		`@1 BAUMGARTNER (Kathy B.)`
A11	`06`	`1`		`@1 HARLAN (Linda C.)`
A11	`07`	`1`		`@1 BERNSTEIN (Leslie)`
A14	`01`			`@1 Department of Preventive Medicine, Keck School of Medicine of the University of Southern California @2 Los Angeles, CA @3 USA @Z 1 aut. @Z 2 aut. @Z 7 aut.`
A14	`02`			`@1 Department of Cancer Etiology, Division of Population Sciences, City of Hope National Medical Center and Comprehensive Cancer Center, 1500 Duarte Road, Bldg. 173 @2 Duarte, CA 91010 @3 USA @Z 2 aut.`
A14	`03`			`@1 Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute @2 Bethesda, MD @3 USA @Z 3 aut. @Z 6 aut.`
A14	`04`			`@1 Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center @2 Seattle, WA @3 USA @Z 4 aut.`
A14	`05`			`@1 Department of Epidemiology & Population Health, University of Louisville @2 Louisville, KY @3 USA @Z 5 aut.`
A20				`@1 383-391`
A21				`@1 2009`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20699 @5 354000186985230230`
A44				`@0 0000 @1 © 2009 INIST-CNRS. All rights reserved.`
A45				`@0 45 ref.`
A47	`01`	`1`		`@0 09-0141950`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Breast cancer research and treatment`
A66	`01`			`@0 NLD`
C01	`01`		`ENG`	@0 Purpose Lymphedema of the arm is a potential complication of breast cancer therapy. This study examines pre-disposing factors that may operate in conjunction with treatment-related factors in the development of arm lymphedema in a large cohort of White and Black breast cancer survivors. Methods 494 women (271 White and 223 Black) with in situ to Stage III-A primary breast cancer completed a baseline interview within 18 months of diagnosis. Information on lymphedema was collected during a follow-up interview, conducted on average 50 months after diagnosis. Self-reported data were used to classify women with or without lymphedema. Multivariable logistic regression models were developed to identify risk factors for arm lymphedema. Results Arm lymphedema was associated with younger age at diagnosis (odds ratio, OR per year of age = 0.96; 95% confidence interval, CI = 0.93-0.99), positive history of hypertension (OR = 2.31; 95% CI = 1.38-3.88), obesity (OR for body mass index, BMI>30 = 2.48; 95% CI = 1.05-5.84) and having had surgery where 10 or more lymph nodes were excised (OR = 2.16; 95% CI = 1.12-4.17). While Black women had higher prevalence of arm lymphedema than White women (28% vs. 21%), race was not associated with lymphedema risk in models adjusted for multiple factors (adjusted OR = 1.01; 95% CI = 0.63-1.63). Conclusion Risk of arm lymphedema did not differ significantly for Black and White women. Risk factors identified in this study offer opportunities for interventions (weight loss, control of blood pressure, use of sentinel node biopsy where possible) for reducing incidence of lymphedema or controlling the symptoms associated with this condition.
C02	`01`	`X`		`@0 002B20E02`
C02	`02`	`X`		`@0 002B12B04`
C02	`03`	`X`		`@0 002B12B05`
C03	`01`	`X`	`FRE`	`@0 Facteur risque @5 01`
C03	`01`	`X`	`ENG`	`@0 Risk factor @5 01`
C03	`01`	`X`	`SPA`	`@0 Factor riesgo @5 01`
C03	`02`	`X`	`FRE`	`@0 Epidémiologie @5 02`
C03	`02`	`X`	`ENG`	`@0 Epidemiology @5 02`
C03	`02`	`X`	`SPA`	`@0 Epidemiología @5 02`
C03	`03`	`X`	`FRE`	`@0 Bras @5 03`
C03	`03`	`X`	`ENG`	`@0 Arm @5 03`
C03	`03`	`X`	`SPA`	`@0 Brazo @5 03`
C03	`04`	`X`	`FRE`	`@0 Lymphoedème @5 04`
C03	`04`	`X`	`ENG`	`@0 Lymphedema @5 04`
C03	`04`	`X`	`SPA`	`@0 Linfedema @5 04`
C03	`05`	`X`	`FRE`	`@0 Cancer du sein @2 NM @5 05`
C03	`05`	`X`	`ENG`	`@0 Breast cancer @2 NM @5 05`
C03	`05`	`X`	`SPA`	`@0 Cáncer del pecho @2 NM @5 05`
C03	`06`	`X`	`FRE`	`@0 Diagnostic @5 06`
C03	`06`	`X`	`ENG`	`@0 Diagnosis @5 06`
C03	`06`	`X`	`SPA`	`@0 Diagnóstico @5 06`
C03	`07`	`X`	`FRE`	`@0 Négroïde @5 07`
C03	`07`	`X`	`ENG`	`@0 Negroid @5 07`
C03	`07`	`X`	`SPA`	`@0 Negroide @5 07`
C03	`08`	`X`	`FRE`	`@0 Race @5 08`
C03	`08`	`X`	`ENG`	`@0 Race @5 08`
C03	`08`	`X`	`SPA`	`@0 Raza @5 08`
C03	`09`	`X`	`FRE`	`@0 Homme @5 09`
C03	`09`	`X`	`ENG`	`@0 Human @5 09`
C03	`09`	`X`	`SPA`	`@0 Hombre @5 09`
C03	`10`	`X`	`FRE`	`@0 Femelle @5 10`
C03	`10`	`X`	`ENG`	`@0 Female @5 10`
C03	`10`	`X`	`SPA`	`@0 Hembra @5 10`
C03	`11`	`X`	`FRE`	`@0 Adulte @5 11`
C03	`11`	`X`	`ENG`	`@0 Adult @5 11`
C03	`11`	`X`	`SPA`	`@0 Adulto @5 11`
C03	`12`	`X`	`FRE`	`@0 Femme @5 12`
C03	`12`	`X`	`ENG`	`@0 Woman @5 12`
C03	`12`	`X`	`SPA`	`@0 Mujer @5 12`
C03	`13`	`X`	`FRE`	`@0 Caucasoïde @5 13`
C03	`13`	`X`	`ENG`	`@0 Caucasoid @5 13`
C03	`13`	`X`	`SPA`	`@0 Caucásico @5 13`
C03	`14`	`X`	`FRE`	`@0 Survivant @5 14`
C03	`14`	`X`	`ENG`	`@0 Survivor @5 14`
C03	`14`	`X`	`SPA`	`@0 Sobreviviente @5 14`
C03	`15`	`X`	`FRE`	`@0 Hypertension artérielle @5 15`
C03	`15`	`X`	`ENG`	`@0 Hypertension @5 15`
C03	`15`	`X`	`SPA`	`@0 Hipertensión arterial @5 15`
C03	`16`	`X`	`FRE`	`@0 Indice masse corporelle @5 16`
C03	`16`	`X`	`ENG`	`@0 Body mass index @5 16`
C03	`16`	`X`	`SPA`	`@0 Indice masa corporal @5 16`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'appareil circulatoire @5 37`
C07	`01`	`X`	`ENG`	`@0 Cardiovascular disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Pathologie des vaisseaux lymphatiques @5 38`
C07	`02`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Linfático patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Tumeur maligne @2 NM @5 39`
C07	`03`	`X`	`ENG`	`@0 Malignant tumor @2 NM @5 39`
C07	`03`	`X`	`SPA`	`@0 Tumor maligno @2 NM @5 39`
C07	`04`	`X`	`FRE`	`@0 Cancer @2 NM`
C07	`04`	`X`	`ENG`	`@0 Cancer @2 NM`
C07	`04`	`X`	`SPA`	`@0 Cáncer @2 NM`
C07	`05`	`X`	`FRE`	`@0 Pathologie de la glande mammaire @2 NM @5 40`
C07	`05`	`X`	`ENG`	`@0 Mammary gland diseases @2 NM @5 40`
C07	`05`	`X`	`SPA`	`@0 Glándula mamaria patología @2 NM @5 40`
C07	`06`	`X`	`FRE`	`@0 Pathologie du sein @2 NM @5 41`
C07	`06`	`X`	`ENG`	`@0 Breast disease @2 NM @5 41`
C07	`06`	`X`	`SPA`	`@0 Seno patología @2 NM @5 41`
N21				`@1 096`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 09-0141950 INIST
ET :	Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women
AU :	MEESKE (Kathleen A.); SULLIVAN-HALLEY (Jane); SMITH (Ashley W.); MCTIERNAN (Anne); BAUMGARTNER (Kathy B.); HARLAN (Linda C.); BERNSTEIN (Leslie)
AF :	Department of Preventive Medicine, Keck School of Medicine of the University of Southern California/Los Angeles, CA/Etats-Unis (1 aut., 2 aut., 7 aut.); Department of Cancer Etiology, Division of Population Sciences, City of Hope National Medical Center and Comprehensive Cancer Center, 1500 Duarte Road, Bldg. 173/Duarte, CA 91010/Etats-Unis (2 aut.); Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute/Bethesda, MD/Etats-Unis (3 aut., 6 aut.); Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center/Seattle, WA/Etats-Unis (4 aut.); Department of Epidemiology & Population Health, University of Louisville/Louisville, KY/Etats-Unis (5 aut.)
DT :	Publication en série; Niveau analytique
SO :	Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2009; Vol. 113; No. 2; Pp. 383-391; Bibl. 45 ref.
LA :	Anglais
EA :	Purpose Lymphedema of the arm is a potential complication of breast cancer therapy. This study examines pre-disposing factors that may operate in conjunction with treatment-related factors in the development of arm lymphedema in a large cohort of White and Black breast cancer survivors. Methods 494 women (271 White and 223 Black) with in situ to Stage III-A primary breast cancer completed a baseline interview within 18 months of diagnosis. Information on lymphedema was collected during a follow-up interview, conducted on average 50 months after diagnosis. Self-reported data were used to classify women with or without lymphedema. Multivariable logistic regression models were developed to identify risk factors for arm lymphedema. Results Arm lymphedema was associated with younger age at diagnosis (odds ratio, OR per year of age = 0.96; 95% confidence interval, CI = 0.93-0.99), positive history of hypertension (OR = 2.31; 95% CI = 1.38-3.88), obesity (OR for body mass index, BMI>30 = 2.48; 95% CI = 1.05-5.84) and having had surgery where 10 or more lymph nodes were excised (OR = 2.16; 95% CI = 1.12-4.17). While Black women had higher prevalence of arm lymphedema than White women (28% vs. 21%), race was not associated with lymphedema risk in models adjusted for multiple factors (adjusted OR = 1.01; 95% CI = 0.63-1.63). Conclusion Risk of arm lymphedema did not differ significantly for Black and White women. Risk factors identified in this study offer opportunities for interventions (weight loss, control of blood pressure, use of sentinel node biopsy where possible) for reducing incidence of lymphedema or controlling the symptoms associated with this condition.
CC :	002B20E02; 002B12B04; 002B12B05
FD :	Facteur risque; Epidémiologie; Bras; Lymphoedème; Cancer du sein; Diagnostic; Négroïde; Race; Homme; Femelle; Adulte; Femme; Caucasoïde; Survivant; Hypertension artérielle; Indice masse corporelle
FG :	Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques; Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein
ED :	Risk factor; Epidemiology; Arm; Lymphedema; Breast cancer; Diagnosis; Negroid; Race; Human; Female; Adult; Woman; Caucasoid; Survivor; Hypertension; Body mass index
EG :	Cardiovascular disease; Lymphatic vessel disease; Malignant tumor; Cancer; Mammary gland diseases; Breast disease
SD :	Factor riesgo; Epidemiología; Brazo; Linfedema; Cáncer del pecho; Diagnóstico; Negroide; Raza; Hombre; Hembra; Adulto; Mujer; Caucásico; Sobreviviente; Hipertensión arterial; Indice masa corporal
LO :	INIST-20699.354000186985230230
ID :	09-0141950

Links to Exploration step

Pascal:09-0141950

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women</title>
<author><name sortKey="Meeske, Kathleen A" sort="Meeske, Kathleen A" uniqKey="Meeske K" first="Kathleen A." last="Meeske">Kathleen A. Meeske</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sullivan Halley, Jane" sort="Sullivan Halley, Jane" uniqKey="Sullivan Halley J" first="Jane" last="Sullivan-Halley">Jane Sullivan-Halley</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Cancer Etiology, Division of Population Sciences, City of Hope National Medical Center and Comprehensive Cancer Center, 1500 Duarte Road, Bldg. 173</s1>
<s2>Duarte, CA 91010</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Smith, Ashley W" sort="Smith, Ashley W" uniqKey="Smith A" first="Ashley W." last="Smith">Ashley W. Smith</name>
<affiliation><inist:fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mctiernan, Anne" sort="Mctiernan, Anne" uniqKey="Mctiernan A" first="Anne" last="Mctiernan">Anne Mctiernan</name>
<affiliation><inist:fA14 i1="04"><s1>Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center</s1>
<s2>Seattle, WA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Baumgartner, Kathy B" sort="Baumgartner, Kathy B" uniqKey="Baumgartner K" first="Kathy B." last="Baumgartner">Kathy B. Baumgartner</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Epidemiology & Population Health, University of Louisville</s1>
<s2>Louisville, KY</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harlan, Linda C" sort="Harlan, Linda C" uniqKey="Harlan L" first="Linda C." last="Harlan">Linda C. Harlan</name>
<affiliation><inist:fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bernstein, Leslie" sort="Bernstein, Leslie" uniqKey="Bernstein L" first="Leslie" last="Bernstein">Leslie Bernstein</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0141950</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0141950 INIST</idno>
<idno type="RBID">Pascal:09-0141950</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000340</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women</title>
<author><name sortKey="Meeske, Kathleen A" sort="Meeske, Kathleen A" uniqKey="Meeske K" first="Kathleen A." last="Meeske">Kathleen A. Meeske</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sullivan Halley, Jane" sort="Sullivan Halley, Jane" uniqKey="Sullivan Halley J" first="Jane" last="Sullivan-Halley">Jane Sullivan-Halley</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Cancer Etiology, Division of Population Sciences, City of Hope National Medical Center and Comprehensive Cancer Center, 1500 Duarte Road, Bldg. 173</s1>
<s2>Duarte, CA 91010</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Smith, Ashley W" sort="Smith, Ashley W" uniqKey="Smith A" first="Ashley W." last="Smith">Ashley W. Smith</name>
<affiliation><inist:fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mctiernan, Anne" sort="Mctiernan, Anne" uniqKey="Mctiernan A" first="Anne" last="Mctiernan">Anne Mctiernan</name>
<affiliation><inist:fA14 i1="04"><s1>Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center</s1>
<s2>Seattle, WA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Baumgartner, Kathy B" sort="Baumgartner, Kathy B" uniqKey="Baumgartner K" first="Kathy B." last="Baumgartner">Kathy B. Baumgartner</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Epidemiology & Population Health, University of Louisville</s1>
<s2>Louisville, KY</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harlan, Linda C" sort="Harlan, Linda C" uniqKey="Harlan L" first="Linda C." last="Harlan">Linda C. Harlan</name>
<affiliation><inist:fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bernstein, Leslie" sort="Bernstein, Leslie" uniqKey="Bernstein L" first="Leslie" last="Bernstein">Leslie Bernstein</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Arm</term>
<term>Body mass index</term>
<term>Breast cancer</term>
<term>Caucasoid</term>
<term>Diagnosis</term>
<term>Epidemiology</term>
<term>Female</term>
<term>Human</term>
<term>Hypertension</term>
<term>Lymphedema</term>
<term>Negroid</term>
<term>Race</term>
<term>Risk factor</term>
<term>Survivor</term>
<term>Woman</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Facteur risque</term>
<term>Epidémiologie</term>
<term>Bras</term>
<term>Lymphoedème</term>
<term>Cancer du sein</term>
<term>Diagnostic</term>
<term>Négroïde</term>
<term>Race</term>
<term>Homme</term>
<term>Femelle</term>
<term>Adulte</term>
<term>Femme</term>
<term>Caucasoïde</term>
<term>Survivant</term>
<term>Hypertension artérielle</term>
<term>Indice masse corporelle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Purpose Lymphedema of the arm is a potential complication of breast cancer therapy. This study examines pre-disposing factors that may operate in conjunction with treatment-related factors in the development of arm lymphedema in a large cohort of White and Black breast cancer survivors. Methods 494 women (271 White and 223 Black) with in situ to Stage III-A primary breast cancer completed a baseline interview within 18 months of diagnosis. Information on lymphedema was collected during a follow-up interview, conducted on average 50 months after diagnosis. Self-reported data were used to classify women with or without lymphedema. Multivariable logistic regression models were developed to identify risk factors for arm lymphedema. Results Arm lymphedema was associated with younger age at diagnosis (odds ratio, OR per year of age = 0.96; 95% confidence interval, CI = 0.93-0.99), positive history of hypertension (OR = 2.31; 95% CI = 1.38-3.88), obesity (OR for body mass index, BMI>30 = 2.48; 95% CI = 1.05-5.84) and having had surgery where 10 or more lymph nodes were excised (OR = 2.16; 95% CI = 1.12-4.17). While Black women had higher prevalence of arm lymphedema than White women (28% vs. 21%), race was not associated with lymphedema risk in models adjusted for multiple factors (adjusted OR = 1.01; 95% CI = 0.63-1.63). Conclusion Risk of arm lymphedema did not differ significantly for Black and White women. Risk factors identified in this study offer opportunities for interventions (weight loss, control of blood pressure, use of sentinel node biopsy where possible) for reducing incidence of lymphedema or controlling the symptoms associated with this condition.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0167-6806</s0>
</fA01>
<fA02 i1="01"><s0>BCTRD6</s0>
</fA02>
<fA03 i2="1"><s0>Breast cancer res. treat.</s0>
</fA03>
<fA05><s2>113</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MEESKE (Kathleen A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SULLIVAN-HALLEY (Jane)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SMITH (Ashley W.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>MCTIERNAN (Anne)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BAUMGARTNER (Kathy B.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>HARLAN (Linda C.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BERNSTEIN (Leslie)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Cancer Etiology, Division of Population Sciences, City of Hope National Medical Center and Comprehensive Cancer Center, 1500 Duarte Road, Bldg. 173</s1>
<s2>Duarte, CA 91010</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center</s1>
<s2>Seattle, WA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Epidemiology & Population Health, University of Louisville</s1>
<s2>Louisville, KY</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>383-391</s1>
</fA20>
<fA21><s1>2009</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20699</s2>
<s5>354000186985230230</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>45 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0141950</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Breast cancer research and treatment</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Purpose Lymphedema of the arm is a potential complication of breast cancer therapy. This study examines pre-disposing factors that may operate in conjunction with treatment-related factors in the development of arm lymphedema in a large cohort of White and Black breast cancer survivors. Methods 494 women (271 White and 223 Black) with in situ to Stage III-A primary breast cancer completed a baseline interview within 18 months of diagnosis. Information on lymphedema was collected during a follow-up interview, conducted on average 50 months after diagnosis. Self-reported data were used to classify women with or without lymphedema. Multivariable logistic regression models were developed to identify risk factors for arm lymphedema. Results Arm lymphedema was associated with younger age at diagnosis (odds ratio, OR per year of age = 0.96; 95% confidence interval, CI = 0.93-0.99), positive history of hypertension (OR = 2.31; 95% CI = 1.38-3.88), obesity (OR for body mass index, BMI>30 = 2.48; 95% CI = 1.05-5.84) and having had surgery where 10 or more lymph nodes were excised (OR = 2.16; 95% CI = 1.12-4.17). While Black women had higher prevalence of arm lymphedema than White women (28% vs. 21%), race was not associated with lymphedema risk in models adjusted for multiple factors (adjusted OR = 1.01; 95% CI = 0.63-1.63). Conclusion Risk of arm lymphedema did not differ significantly for Black and White women. Risk factors identified in this study offer opportunities for interventions (weight loss, control of blood pressure, use of sentinel node biopsy where possible) for reducing incidence of lymphedema or controlling the symptoms associated with this condition.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B20E02</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B12B04</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B12B05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Bras</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Arm</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Brazo</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Breast cancer</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Négroïde</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Negroid</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Negroide</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Race</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Race</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Raza</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Homme</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Human</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Hombre</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Femelle</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Female</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Hembra</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Adulte</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Adult</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Adulto</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Femme</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Woman</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Mujer</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Caucasoïde</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Caucasoid</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Caucásico</s0>
<s5>13</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Survivant</s0>
<s5>14</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Survivor</s0>
<s5>14</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Sobreviviente</s0>
<s5>14</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Hypertension artérielle</s0>
<s5>15</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Hypertension</s0>
<s5>15</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Hipertensión arterial</s0>
<s5>15</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Indice masse corporelle</s0>
<s5>16</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Body mass index</s0>
<s5>16</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Indice masa corporal</s0>
<s5>16</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Breast disease</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Seno patología</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fN21><s1>096</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 09-0141950 INIST</NO>
<ET>Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women</ET>
<AU>MEESKE (Kathleen A.); SULLIVAN-HALLEY (Jane); SMITH (Ashley W.); MCTIERNAN (Anne); BAUMGARTNER (Kathy B.); HARLAN (Linda C.); BERNSTEIN (Leslie)</AU>
<AF>Department of Preventive Medicine, Keck School of Medicine of the University of Southern California/Los Angeles, CA/Etats-Unis (1 aut., 2 aut., 7 aut.); Department of Cancer Etiology, Division of Population Sciences, City of Hope National Medical Center and Comprehensive Cancer Center, 1500 Duarte Road, Bldg. 173/Duarte, CA 91010/Etats-Unis (2 aut.); Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute/Bethesda, MD/Etats-Unis (3 aut., 6 aut.); Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center/Seattle, WA/Etats-Unis (4 aut.); Department of Epidemiology & Population Health, University of Louisville/Louisville, KY/Etats-Unis (5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2009; Vol. 113; No. 2; Pp. 383-391; Bibl. 45 ref.</SO>
<LA>Anglais</LA>
<EA>Purpose Lymphedema of the arm is a potential complication of breast cancer therapy. This study examines pre-disposing factors that may operate in conjunction with treatment-related factors in the development of arm lymphedema in a large cohort of White and Black breast cancer survivors. Methods 494 women (271 White and 223 Black) with in situ to Stage III-A primary breast cancer completed a baseline interview within 18 months of diagnosis. Information on lymphedema was collected during a follow-up interview, conducted on average 50 months after diagnosis. Self-reported data were used to classify women with or without lymphedema. Multivariable logistic regression models were developed to identify risk factors for arm lymphedema. Results Arm lymphedema was associated with younger age at diagnosis (odds ratio, OR per year of age = 0.96; 95% confidence interval, CI = 0.93-0.99), positive history of hypertension (OR = 2.31; 95% CI = 1.38-3.88), obesity (OR for body mass index, BMI>30 = 2.48; 95% CI = 1.05-5.84) and having had surgery where 10 or more lymph nodes were excised (OR = 2.16; 95% CI = 1.12-4.17). While Black women had higher prevalence of arm lymphedema than White women (28% vs. 21%), race was not associated with lymphedema risk in models adjusted for multiple factors (adjusted OR = 1.01; 95% CI = 0.63-1.63). Conclusion Risk of arm lymphedema did not differ significantly for Black and White women. Risk factors identified in this study offer opportunities for interventions (weight loss, control of blood pressure, use of sentinel node biopsy where possible) for reducing incidence of lymphedema or controlling the symptoms associated with this condition.</EA>
<CC>002B20E02; 002B12B04; 002B12B05</CC>
<FD>Facteur risque; Epidémiologie; Bras; Lymphoedème; Cancer du sein; Diagnostic; Négroïde; Race; Homme; Femelle; Adulte; Femme; Caucasoïde; Survivant; Hypertension artérielle; Indice masse corporelle</FD>
<FG>Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques; Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein</FG>
<ED>Risk factor; Epidemiology; Arm; Lymphedema; Breast cancer; Diagnosis; Negroid; Race; Human; Female; Adult; Woman; Caucasoid; Survivor; Hypertension; Body mass index</ED>
<EG>Cardiovascular disease; Lymphatic vessel disease; Malignant tumor; Cancer; Mammary gland diseases; Breast disease</EG>
<SD>Factor riesgo; Epidemiología; Brazo; Linfedema; Cáncer del pecho; Diagnóstico; Negroide; Raza; Hombre; Hembra; Adulto; Mujer; Caucásico; Sobreviviente; Hipertensión arterial; Indice masa corporal</SD>
<LO>INIST-20699.354000186985230230</LO>
<ID>09-0141950</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000340 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000340 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:09-0141950
   |texte=   Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri